ANTI CANCER MEDICATION
200 mg SORATIB Sorafenib IP Tablets
Price on Request
SORATIB 200 mg (Sorafenib IP) is an oral targeted cancer medication. Manufactured by Samarth Life Sciences, it inhibits multiple kinases to treat advanced liver cancer (hepatocellular carcinoma), kidney cancer (renal cell carcinoma), and thyroid cancer. It acts by cutting off the blood supply that tumor cells need to multiply.
liketo.usa,uk,china,southkorea,russia,japan,singapore
liketo.usa,uk,china,southkorea,russia,japan,singapore
Composition
Strength 200 mg
Packaging Size 30 Tablets
Form Tablet
Country of Origin Made in India
Usage/Application Clinic
Manufacturer Samarth
Brand Soratib
Packaging Type Bottle
Composition Sorafenib Tablets IP
Minimum order quantity: 50 Bottle
Enquire About This Product
